Celgosivir hydrochloride
Sponsors
Hoechst Marion Roussel
Conditions
HIV Infections
Phase 1
Phase 2
A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
CompletedNCT00002150
Target: 200Updated: 2005-06-24
A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients
CompletedNCT00002151
Target: 200Updated: 2005-06-24